Skip to main content

Gilead Sciences Invests in Research for COVID-19 Treatments for All Ages

By: 3BL Media

SOURCE: Gilead Sciences

DESCRIPTION:

Children are being hospitalized with COVID 19 at increasingly high rates, and those younger than 5 aren't eligible to receive a vaccine. We’re committed to helping in this area by investing in research for COVID-19 treatments for all ages.

About Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

Originally published by Gilead Sciences.

Tweet me: .@GileadSciences is committed to helping children being hospitalized with #COVID19 by investing in research for COVID-19 treatments for all ages. #CROI2022 https://bit.ly/3GNxutP

KEYWORDS: NASDAQ: GILD, COVID-19, CROI2022

Chart showing increase in COVID-19 hospitalizations among children in the US

Recent Quotes

View More
Symbol Price Change (%)
AMZN  206.35
+5.20 (2.59%)
AAPL  265.50
+1.62 (0.61%)
AMD  201.85
-1.23 (-0.61%)
BAC  53.44
+0.70 (1.33%)
GOOG  304.35
+1.53 (0.50%)
META  639.64
+0.35 (0.05%)
MSFT  402.17
+5.31 (1.34%)
NVDA  190.34
+5.37 (2.90%)
ORCL  156.31
+2.34 (1.52%)
TSLA  416.07
+5.44 (1.32%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.